Bangalore, Karnataka -- (SBWIRE) -- 03/14/2017 -- General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions

By far, the fastest growing segment over the forecast period is represented by microfracture adjunct market. The procedure is complementary to microfracture which provides a very large market for implant sales to penetrate. No other segment is expected to grow as strongly.

Microfracture procedures are the standard to which new products and procedures are compared. Their positive results and low cost creates barriers for new product entry, as new products and procedures on the market must surpass microfracture procedures in terms of cost or efficacy.

Surgeons repairing cartilage damage are no doubt awaiting new technological developments which may likely involve stem cell products offered at more competitive prices. However, an implant that will truly impact the market by providing clinically backed, long-term cartilage repair at low cost remains years away.

Cartilage is a connective tissue that lines the ends of bones. It provides shock absorption within the joint and prevents abrasion from occurring to the articular surfaces of bone. Cartilage, in its various forms, is found in intervertebral discs, as the articular lining for joint surfaces and in the meniscal pads of the knees. All types of cartilage are poorly vascularized and, as proper healing requires adequate blood flow, are some of the slowest healing tissues of the body.
Osteoarthritis is cumulative trauma that eventually wears away at cartilaginous surfaces, exposing the underlying bone to additional wear. There are few alternatives for osteobiologic cartilage repair. Damage to cartilage is difficult to treat because the tissue lacks blood supply and has limited capacity for self-repair.

Spanning over 464 pages "US Market Report for Orthopedic Cartilage Repair 2017 - MedCore" report covers Executive Summary, U.S. Orthopedic Biomaterials Market Overview, Competitive Analysis, Market Trends, Market Development, Research Methodology, Disease Overview, Orthopedic Cartilage Repair Market, Appendix. The report covered companies are - Medtronic, Genzyme, DePuy Synthes, Anika Therapeutics, Ferring Pharmaceuticals, Stryker, NuVasive, Bioventus, Zimmer Biomet, Integra LifeSciences, RTI Surgical, Fidia Pharmaceuticals, MTF, Orthofix, Arthrex, AlloSource, Aastrom, Baxter, Harvest Technologies, Wright Medical, Bacterin International, Arteriocyte, Exactech, LifeNet Health, Biocomposites, Alphatec Spine, Celling Biosciences, Globus Medical, Nuo Therapeutics, K2M

For more information Visit at: http://www.drugpipeline.net/idata-research/us-market-report-orthopedic-cartilage-repair-2017-medcore

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.